Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Mar 3:11:1042509.
doi: 10.3389/fped.2023.1042509. eCollection 2023.

Intra-arterial vasodilators infusion for management of reversible cerebral vasoconstriction syndrome in a 12-year-old girl: A case report

Affiliations
Case Reports

Intra-arterial vasodilators infusion for management of reversible cerebral vasoconstriction syndrome in a 12-year-old girl: A case report

Frida Rizzati et al. Front Pediatr. .

Abstract

Reversible cerebral vasoconstriction syndrome (RCVS) is a vascular disease characterized by diffuse transient vasoconstriction and vasodilatation of the cerebral arteries. It is commonly associated with recurrent severe acute headaches with or without focal neurological deficits due to hemorrhages, infarcts, and even posterior reversible encephalopathy syndrome. The optimal management of acute neurologic deficits caused by RCVS is still uncertain. Calcium channel blockers (CCBs) such as nimodipine or verapamil have been reported to be effective in adult series. Intra-arterial injection of nimodipine, verapamil, and milrinone has recently been demonstrated to be safe and effective for treating severe segmental vasoconstriction in adults. CCBs are the most used treatment in the available pediatric literature. Intra-arterial vasodilators have been reported in some rare pediatric reports with more severe diseases, but their utility is still under investigation. We report a case of a 12-year-old girl who underwent a severe course of RCVS complicated by multiple cerebral infarcts, treated by several sessions of intra-arterial vasodilators infusion.

Keywords: case report; children; headache; pediatric intensive care unit; reversible cerebral vasoconstriction syndrome; vessel wall MRI.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Day 4 MRI with TOF sequence (A) and 3D SPACE T1 imaging of the vessel wall before (B) and after gadolinium injection (C). The reconstruction of (B) and (C) images follows the dotted line on the TOF sequence (A: dotted line). For easy identification, the internal carotid artery is surrounded by a dotted circle on (B) and (C). On the TOF sequence, the right internal carotid artery is occluded and the right anterior circulation is supplied downstream by the right PComm and AComm. On vessel wall imaging, there is a spontaneous marginalized and asymmetric hyperintense signal (B, arrow) that enhances after injection of gadolinium, without enhancement of the vessel wall itself (C), highly indicative of a wall hematoma due to focal intradural dissection of the right internal carotid artery. MRI, magnetic resonance imaging; PComm, posterior communicating artery; AComm, anterior communicating artery.
Figure 2
Figure 2
Subtracted DSA on day 12 before any vasodilator infusion (A) and after the first vasodilator infusion (B). The cerebral arteries showed diffuse and severe stenosis (A, arrows), which were improved after the first intra-arterial vasodilator infusion. In particular, blood flow reappeared in a pericallosal branch (B, arrow). On the last follow-up DSA, after the last vasodilator infusion 10 days after the first DSA, the stenosis had almost disappeared with a near-normal appearance of the cerebral arteries (C). DSA, digital angiography.

References

    1. Singhal AB, Hajj-Ali RA, Topcuoglu MA, Fok J, Bena J, Yang D, et al. Reversible cerebral vasoconstriction syndromes: analysis of 139 cases. Arch Neurol. (2011) 68(8):1005–12. 10.1001/archneurol.2011.68 - DOI - PubMed
    1. Coffino SW, Fryer RH. Reversible cerebral vasoconstriction syndrome in pediatrics: a case series and review. J Child Neurol. (2017) 32(7):614–23. 10.1177/0883073817696817 - DOI - PubMed
    1. Calabrese LH, Dodick DW, Schwedt TJ, Singhal AB. Narrative review: reversible cerebral vasoconstriction syndromes. Ann Intern Med. (2007) 146(1):34–44. 10.7326/0003-4819-146-1-200701020-00007 - DOI - PubMed
    1. Maldonado-Soto AR, Fryer RH. Reversible cerebral vasoconstriction syndrome in children: an update. Semin Pediatr Neurol. (2021) 40:100936. 10.1016/j.spen.2021.100936 - DOI - PubMed
    1. Singhal AB, Topcuoglu MA. Glucocorticoid-associated worsening in reversible cerebral vasoconstriction syndrome. Neurology. (2017) 88(3):228–36. 10.1212/WNL.0000000000003510 - DOI - PMC - PubMed

Publication types

LinkOut - more resources